• Services
    • M&A Advisory
    • Manufacturing Consulting
    • Executive Recruitment
  • Success Stories
  • Team
  • About
  • News & Blog
  • Contact

MDO Article: Bringing Medical Device Manufacturing Back to the U.S.

January 9, 2018Featured, MedTech, MedTech M&A, News, Published FeaturesRebecca MacLeod

John Thomas, Managing Director of Bonifacio Consulting’s Technical Practice, recently contributed an article to Medical Design & Outsourcing featuring work with Vascular Pathways. The article outlines a compelling case study of one company’s experience moving their contract manufacturing (CM) operations back to the United States. John details insightful lessons-learned from the experience, and tips that can help any medical device OEM who is considering a move to a new CM, or selecting their CM for the first time.

Here’s a sneak peek of the article:

Deciding where and how to manufacture a product is without a doubt one of the most important decisions a medical device OEM faces. This decision has many implications, from the overall successful manufacture of the product to the impact on the bottom line of the organization. To complicate matters, there are so many factors to be contemplated to ensure that a good manufacturing partner is selected, and once that manufacturing line is set, changing suppliers can be both challenging and expensive. One of the most common questions in any OEM’s mind is whether or not manufacturing on-shore or off-shore makes the most sense.

Vascular Pathways was a medical technology company focused on developing and commercializing novel vascular access devices via proprietary integrated nitinol guidewire technology. The company was growing and expanding their product line, but this presented problems in manufacturing. Their existing contract manufacturer (CM) in Tijuana wasn’t meeting production numbers with the current product line, and the company was cueing up the launch of their next generation product. At this critical point for the organization, Vascular Pathways was faced with the difficult decision of changing CM’s and also whether or not to bring manufacturing back to the U.S.

Read the full piece on Medical Design & Outsourcing.

Previous post Takeaways from MEDICA 2017 Next post MD&M West: February 6-8, 2018

Media

Media Contact:
Mark Bonifacio
President
mark@bonifacioconsulting.com

Company Information

  • About Us
  • Winds of Change (article)
  • MDO Then & Now (article)

Categories

  • Events
  • Featured
  • MedTech
  • MedTech M&A
  • News
  • Published Features
  • Uncategorized

More About BCS

The BCS team has developed solid relationships with exceptional people throughout Medical Device manufacturing. This has resulted in a network that is second to none. Our network is designed to be leveraged to achieve maximum enterprise value through world class operational excellence, aggressive business development and superior M&A execution.

More

BCS Events

  • MEDICA 2022: November 14-17
  • MD&M West 2022: April 12-14

More

Contact Info

(310) 683-3257
info@bonifacioconsulting.com
Twitter
LinkedIn
HomeM&A AdvisoryManufacturing ConsultingExecutive RecruitmentContact UsAbout UsBlog
© 2017 Copyright - Bonifacio Consulting Services